Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Agios Pharmaceuticals (AGIO)

Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Agios Pharmaceuticals 88 SIDNEY STREET CAMBRIDGE MA 02139 USA

www.agios.com P: 617-649-8600

Description:

Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases.

Key Statistics

Overview:

Market Capitalization, $K 2,567,842
Enterprise Value, $K 2,479,632
Shares Outstanding, K 56,773
Annual Sales, $ 26,820 K
Annual Net Income, $ -352,090 K
Last Quarter Sales, $ 8,190 K
Last Quarter Net Income, $ -81,550 K
EBIT, $ -392,950 K
EBITDA, $ -391,380 K
60-Month Beta 0.77
% of Insider Shareholders 4.93%
Float, K 53,974
% Float 95.07%
Short Volume Ratio 0.51

Growth:

1-Year Return 71.64%
3-Year Return -18.84%
5-Year Return -1.22%
5-Year Revenue Growth -71.59%
5-Year Earnings Growth -4.98%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.45 on 05/02/24
Next Earnings Date 08/01/24
Earnings Per Share ttm -6.32
EPS Growth vs. Prev Qtr 15.70%
EPS Growth vs. Prev Year 1.36%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AGIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.41%
Return-on-Assets % -36.36%
Profit Margin % -1,312.79%
Debt/Equity 0.00
Price/Sales 95.71
Price/Cash Flow N/A
Price/Book 3.24
Book Value/Share 13.10
Interest Coverage -1.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar